[Treatment of panmyelopathies].
D000728:Androgens / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001792:Blood Platelets; D001803:Blood Transfusion; D001855:Bone Marrow Diseases / Q000628:therapy*; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D004912:Erythrocytes; D004921:Erythropoietin / Q000096:biosynthesis; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006648:Histocompatibility; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014184:Transplantation, Homologous
D000728:Androgens; D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D004921:Erythropoietin; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone
Behandlung der Panmyelopathie.